|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fenthion | CAS 55-38-9 | ||
| C10H15O3PS | RTECS TF9625000 | ||
|
Synonyms & Trade Names Baytex; Entex; O,O-Dimethyl O-3-methyl-4-methylthiophenyl phosphorothioate |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: See Appendix D | ||
| OSHA PEL†: none | |||
| IDLH N.D. See: IDLH INDEX | Conversion | ||
|
Physical Description Colorless to brown liquid with a slight, garlic-like odor. [insecticide] |
|||
|
MW: 278.3 |
BP: ? |
FRZ: 43°F |
Sol: 0.006% |
|
VP: 0.0003 mmHg |
IP: ? |
|
Sp.Gr: 1.25 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Liquid | |||
|
Incompatibilities & Reactivities Oxidizers |
|||
|
Measurement Method None available See: NMAM INDEX |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, giddiness, vertigo (an illusion of movement), weakness; rhinorrhea (discharge of thin nasal mucous), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasiculation; dyspnea (breathing difficulty) | |
|
Target Organs
respiratory system, central nervous system, cardiovascular system, plasma cholinesterase |
|
| See also: INTRODUCTION See ICSC CARD: 0655 |